Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldInterest DepositsLiabilities and Shareholders EquityLoans - AdjustmentsLoans - GrossLoans - Loss AllowanceLoans - NetNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesProperty, Plant & Equipment (Net)Retained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MainStreet Bancshares (MNSBP) Common Equity (2021 - 2025)

Historic Common Equity for MainStreet Bancshares (MNSBP) over the last 5 years, with Q3 2025 value amounting to $218.4 million.

  • MainStreet Bancshares' Common Equity fell 340.1% to $218.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $218.4 million, marking a year-over-year decrease of 340.1%. This contributed to the annual value of $208.0 million for FY2024, which is 610.61% down from last year.
  • According to the latest figures from Q3 2025, MainStreet Bancshares' Common Equity is $218.4 million, which was down 340.1% from $213.5 million recorded in Q2 2025.
  • In the past 5 years, MainStreet Bancshares' Common Equity ranged from a high of $226.1 million in Q3 2024 and a low of $172.2 million during Q1 2021
  • For the 5-year period, MainStreet Bancshares' Common Equity averaged around $203.4 million, with its median value being $208.0 million (2024).
  • Its Common Equity has fluctuated over the past 5 years, first surged by 1249.63% in 2023, then crashed by 610.61% in 2024.
  • MainStreet Bancshares' Common Equity (Quarter) stood at $188.8 million in 2021, then rose by 5.03% to $198.3 million in 2022, then rose by 11.72% to $221.5 million in 2023, then fell by 6.11% to $208.0 million in 2024, then rose by 4.99% to $218.4 million in 2025.
  • Its Common Equity stands at $218.4 million for Q3 2025, versus $213.5 million for Q2 2025 and $209.6 million for Q1 2025.